Loading...
Loading...
Browse all stories on DeepNewz
VisitProfluentBio Launches OpenCRISPR: AI-Generated Gene Editor with Modest Impact
Apr 23, 2024, 01:49 AM
ProfluentBio has announced the launch of OpenCRISPR, a groundbreaking open-source AI-generated gene editor. Developed using ProfluentBio's large language models, this tool includes a Cas9-like protein and guide RNA, designed to edit human DNA with modest on-target activity. The initiative, which aims to democratize access to gene editing technology, has the potential to revolutionize biomedicine but is not expected to impact clinical editing in the next 3 years. The sequences and molecules designed by AI have been freely released under the OpenCRISPR initiative, marking a significant milestone in personalized medicine.
View original story
Markets
Yes • 50%
No • 50%
Major news outlets and bioethics publications.
Yes • 50%
No • 50%
Research publications and citations in academic journals.
No • 50%
Yes • 50%
U.S. Patent and Trademark Office (USPTO) filings.
Therapeutic applications • 25%
Research tools • 25%
Personalized medicine • 25%
Diagnostic tools • 25%
Scientific publications and industry reports.
Agriculture • 33%
Livestock breeding • 34%
Biomedicine • 33%
Industry press releases, reports, and news.
North America • 25%
Europe • 25%
Asia-Pacific • 25%
Rest of World • 25%
Global biotechnology adoption reports and regional health regulatory updates.